For the purposes of paragraph 1(b ) , the Member States shall cooperate , under the coordination of the Executive Director of the Agency , in order to ensure that the final composition of the Committee for Advanced Therapies provides appropriate and balanced coverage of the scientific areas relevant to advanced therapies , including medical devices , tissue engineering , gene therapy , cell therapy , biotechnology , surgery , pharmacovigilance , risk management and ethics .